New Warning Labels for Opioids

FDA applies black-box warning to mixing opioids and benzodiazepines in an effort to prevent overdoses.

Opioid Label / Photo: Associated Press
Opioid Label / Photo: Associated Press

A recent CNN article discussed the FDA’s recent action to warn consumers of the dangers of mixing opioids and benzodiazepines. As the result of a citizen petition, the FDA has enforced black-box warnings, which is the highest-level warning. In the period from 2004 to 2011, the number of overdose deaths from mixing these two drugs has tripled, and the number of patients prescribed both a narcotic and a benzodiazepine has gone up 41%.

Now, when a patient gets their prescription filled, the bottle should have a notification that indicates a black-box warning for the drug, but the consumer will need to visit the manufacturer’s website for details. "It is nothing short of a public health crisis when you see a substantial increase of avoidable overdose and death related to two widely used drug classes being taken together,” said FDA Commissioner, Robert Califf.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report